Estrogens control inflammation in experimental colitis

Journal of Biological Regulators and Homeostatic Agents

Volumn 28, Issue 2, 2014, Pages 213-224

  Hajj Hussein, I ^a,b   Eid, A ^a   Maksoud, R ^a   Jambart, S ^a   Bou Assi, T ^a   Zgheib, Z ^a   Oueidat, D ^a   Chams, N ^a   Chams, S ^a   Diab, R ^a   Barada, K ^a   Jurjus, R ^c   Cappello, F ^d   Reimund, J ^e   Kreiker, J ^f   Leone, A ^d   Jurjus, Abdo ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Colitis; Estrogen; Fibronectin; IL 1 ; Inflammatory bowel diseases; Mast cells; TNF

Indexed keywords

ANIMALS; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; ESTROGENS; FIBRONECTINS; INFLAMMATION; MALE; MAST CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84905640056     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Straub RH. The complex role of estrogens in inflammation. Endocr rev 2007; 28:521-74. (Pubitemid 47236336)
2. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr rev 1996; 17:369-84. (Pubitemid 26277980)
3. Yamada K, Hayashi T, Kuzuya M, Naito M, Asai K, Iguchi A. Physiological concentration of 17β-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein 1. Artery 1996; 22:24-35. (Pubitemid 26172406)
4. Ralston SH, Russell RG, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res 1990; 5:983-88. (Pubitemid 20307116)
5. Sato T, Ito A, Mori Y, Yamashita K, Hayakawa T, Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Bio Chem J 1991; 275:645-50.
6. Barth A, Landmann G, Liepold K, Zapf H, Müller D, Karge E, Klinger W. Influence of oestrogens on formation of reactive oxygen species in liver microsomes of differently aged male Wistar rats. Exp Toxico Pathol 1999; 51:282-88. (Pubitemid 29334353)
7. Kawasaki T, Ushiyama T, Inoue K, Hukuda S. Effects of estrogen on interleukin-6 production in rheumatoid fibroblast-like synoviocytes. Clin Exp Rheumatol 2000; 18:743-45.
8. Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, Keith JC Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2004; 286:G118-25. (Pubitemid 38055845)
9. Verdú EF, Deng Y, Bercik P, Collins SM. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2002; 283:G27-36. (Pubitemid 34666159)
10. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004; 50:81-92. (Pubitemid 39286320)
11. Hajj Hussein IA, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol 2008; 14:4028-39.
12. Borm M, Bouma G. Animal models of inflammatory bowel diseases. Drug Discovery Today: Dis Mod 2004; 1:437-43. (Pubitemid 41123754)
13. Imaoka M, Kato M, Tago S, Gotoh M, Satoh H, Manabe S. Effects of estradiol treatment and/or ovariectomy on spontaneous hemorrhagic lesions in the pancreatic islets of Sprague-Dawley rats. Toxicol Pathol 2009; 37:218-26.
14. Satoh H, Sato F, Takami K, Szabo S. New ulcerative colitis model induced by sulfhydryl blockers in rats and the effects of antiinflammatory drugs on the colitis. Jpn J Pharmacol 1997; 73:299-309. (Pubitemid 27226161)
15. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795-803. (Pubitemid 19057602)
16. Fan J, Yu LH, Zhang Y, Ni X, Ma B, Burnstock G. Estrogen altered visceromotor reflex and P2X(3) mRNA expression in a rat model of colitis. Steroids 2009; 74:956-62.
17. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2:541546.
18. Chung HL, Yue GG, To KF, Su YL, Huang Y, Ko WH. Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J Gastroenterol 2007; 13:5605-11. (Pubitemid 350031481)
19. Azuma YT, Nishiyama K, Matsuo Y, Kuwamura M, Morioka A, Nakajima H, Takeuchi T. PPARα contributes to colonic protection in mice with DSS-induced colitis. Int Immunopharmacolm 2010; 10:1261-67.
20. Bindokas VP, Jordán J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 1996; 16:1324-36. (Pubitemid 26145913)
21. Rivera A, Maxwell SA. The p53-induced gene-6 6 oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 2005; 280:29346-54. (Pubitemid 41161390)
22. Hajj Hussein AI, Freund JN, Reimund JM, Shams A, Yamine M, Leone A, Jurjus AR. Enteropathogenic E. coli sustains iodoacetamide-induced ulcerative colitis-like colitis in rats: modulation of IL-1beta, IL-6, TNF-alpha, COX-2, and apoptosisi. J Biol Regul Homeost Agents 2012; 26:515-26.
23. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82:1298-305. (Pubitemid 28294749)
24. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vásquez-Vivar J, Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 2003; 34:1359-68. (Pubitemid 36570409)
25. Motavallian-Naeini A., Minaiyan M, Rabbani M, Mahzuni P. Anti-inflammatory effect of ondansetron through 5HT3 receptors on TNBS-induced coloitis in rat. EXCLI J 2012; 11:30-44.
26. Zhou YH, Yu JP, Liu YF, et al. Effects of ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-α, NF-κ Bp65, IL-6) in TNBS-induced colitis in rats. Mediators Inflamm 2006; 2006:92642.
27. La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J Vet Sci 2004; 5:319-24.
28. Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3, 3′-digallate correlates with inhibition of IKK and NF-κB activation. Br J Pharmacol 2006; 149:121-31. (Pubitemid 44299075)
29. Rieder F, Fiocchi C. Intestinal fibrosis in IBD - a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 2009; 6:228-35.
30. Hamamoto N, Maemura K, Hirata I, Murano M, Sasaki S, Katsu K. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules endothelial leucocyte adhesion molecule-1 (ELAM-1) or intracellular adhesion molecule-1 (ICAM-1)) Clin Exp Immunol 1999; 117:462-68. (Pubitemid 29398291)